You are here

Large Vessels and Big Impact in Acute Stroke

Register for this symposium on Large Vessels and Big Impact in Acute StrokeOriginal Program Date: April 27, 2016
Estimated Time: 1 hour
Release Date: 

This activity is jointly provided by Medical Education Resources and National Stroke Association.

Program Overview

Acute strokes due to large vessel occlusion are among the most serious types of stroke, with a high mortality rate. Endovascular treatment is an effective treatment for large vessel occlusions and can reduce mortality and disability. Large Vessels and Big Impact in Acute Stroke program aims to raise awareness about the effectiveness of organizational coordination and processes that can decrease time delays, increase treatment time, and improve large vessel occlusion outcomes in patients.

Purpose Statement

To educate nurses and health care professionals on the effectiveness of timely endovascular treatment to reduce mortality and disability among acute stroke patients. 

Goals and Objectives

  • Identify the indications of endovascular therapy for acute ischemic stroke.
  • Define areas of uncertainty in stroke care and with the best evidence to assist with the decision-making process in those situations.
  • Describe the shift in standard of care that has challenged traditional prehospital and hospital-based responses to acute stroke patients.
  • Summarize the roles of key personnel in the evaluation and treatment of acute stroke patients.
  • Assess selection of patients for endovascular stroke therapy (application of practical approach that incorporates clinical and imaging information to determine the best possible outcomes for each patient.)
  • Review how specific imaging modalities were used in recent trials and the potential applications in routine clinical practice of endovascular therapy. 

Target Audience

Large Vessels & Big Impact in Acute Stroke is targeted at stroke nurse coordinators.

Nursing Credit

Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This CE activity provides 1 contact hour of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.

For questions regarding this activity, please contact Medical Education Resources or National Stroke Association.

Participation

This webinar is designed for individual participation. Each individual must register for the event and complete the post-assessment along with the evaluation in order to receive proper credit. 

Content Developed and Presented by

David S. Liebeskind, MD,FAAN, FAHA, FANA
Professor of Neurology, UCLA
Director, Outpatient Stroke and Neurovascular Programs
Director, UCLA Cerebral Blood Flow Labortory
Director, UCLA Vascular Neurology Residency Program
Associate Neurology Director, UCLA Stroke Center

Raul G. Nogueira, MD 
Director, Neuroendovascular Service
Marcus Stroke & Neuroscience Center
Grady Memorial Hospital
Associate Professor of Neurology, Neurosurgery and Radiology,
Emory University School of Medicine
President, Society of Vascular & Interventional Neurology (SVIN)
Editor-in-Chief, Interventional Neurology Journal

Anne W. Alexandrov, PhD, RN, CCRN, NVRN-BC, ANVP-BC, AGACNP-BC, FAAN
Professor & NET SMART Program Director
Health Outcomes Institute
Professor, University of Tennessee Health Science Center
Professor & U.S. Principle Investigator
International Stroke Nursing Research Collaboration
Australian Catholic University, Sydney

Disclosure of Conflict of Interest

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty Disclosures

The faculty reported the following financial relationships with commercial interests who products or services may be mentioned in this CME activity:

Name of Faculty Reported Financial Relationship
Dr. Liebeskind, MD, FAAN, FAHA, FANA Stryker and Medtronic
Dr. Nogueira, MD Stryker, Covidien, Penumbra and Interventional Neurology Journal
Dr. Alexandrov, PhD, RN, CCRN, NVRN-BC, ANVP-BC, AHACNP-BC, FAAN Genentech Speakers Bureau, Chiesi (Cardene) Speakers Bureau, The Joint Commission technical advisory panel for measure and development, the Joint commission comprehensive stroke center standards development committee, ICH performance measure writing group of the AHA/ASA, and Co-author Coagulopathic ICH reversal Guidelines, Neurocritical Care Society

 

Name of Content Manager Reported Financial Relationship
Shellea Owens, National Stroke Association No financial relationships to disclose
MER content managers No financial relationships to disclose

Disclaimer

The content and views presented in this educational activity are those of the presenters  and do not necessarily reflect those of Medical Education Resources, National Stroke Association, and/or Stryker. The presenters have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations.. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

MER’s Privacy Policy

Large Vessels and Big Impact in Acute Stroke activity is supported by an educational grant from Stryker.

Register Now

*This event is not part of the official International Stroke Conference 2016 as planned by the International Stroke Conference Program Committee.

Additional Resources

Find a Support Group

Go

Get Involved

 

For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.